US 9657269
Regulatory B cells (tBREGS) and their use
granted A61KA61K2035/122A61K2035/124
Quick answer
US patent 9657269 (Regulatory B cells (tBREGS) and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2035/122, A61K2035/124, A61K2239/31, A61K2239/38